Juluca Tablet, Film Coated
Product Images NDC 49702-242

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Juluca (NDC 49702-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dolutegravir Sodium Chemical Structure (Juluca Spl Graphic 01)

Chemical structure of the active ingredient dolutegravir sodium, part of the combination medication Juluca (dolutegravir sodium and rilpivirine hydrochloride). The structure displays its molecular arrangement with distinctive functional groups and atoms.*

FDA Label Image

Rilpivirine Hydrochloride Chemical Structure (Juluca Spl Graphic 02)

Chemical structure of rilpivirine hydrochloride, an active ingredient in Juluca tablets containing dolutegravir sodium and rilpivirine hydrochloride.*

FDA Label Image

Juluca 30 Count Label (Juluca Spl Graphic 03)

The packaging label for Juluca tablets contains 50 mg dolutegravir sodium and 25 mg rilpivirine hydrochloride per film-coated tablet. The label indicates a quantity of 30 tablets, with medication and storage information, and includes the ViiV Healthcare Company name and logo. It shows the product NDC 49702-242-13 and a QR code linked to www.Juluca.com.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.